4
Changes in Ownership
Actinium Pharmaceuticals, Inc. Filed Acc 0000921895-16-004701
10% owner sold 36,400 shares at an average $1.90 ($69,236)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Memorial Sloan-Kettering Cancer Center 10% owner | 2016-05-25 | Sale | −26,000 | $1.90 | $49,400 | 5,427,313 | D: show line 1 in the form |
| Memorial Sloan-Kettering Cancer Center 10% owner | 2016-05-25 | Sale | −400 | $1.90 | $761 | 5,426,913 | D: show line 2 in the form |
| Memorial Sloan-Kettering Cancer Center 10% owner | 2016-05-25 | Sale | −5,300 | $1.91 | $10,097 | 5,421,613 | D: show line 3 in the form |
| Memorial Sloan-Kettering Cancer Center 10% owner | 2016-05-25 | Sale | −4,600 | $1.91 | $8,786 | 5,417,013 | D: show line 4 in the form |
| Memorial Sloan-Kettering Cancer Center 10% owner | 2016-05-25 | Sale | −100 | $1.92 | $192 | 5,416,913 | D: show line 5 in the form |
| Open-market sales · 36,400 sh · avg $1.90 · $69,236 | |||||||
Loading xslF345X03/form410109001_05262016.xml…